171
Views
6
CrossRef citations to date
0
Altmetric
Review Articles

Therapeutic approaches of trophic factors in animal models and in patients with spinal cord injury

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-15 | Received 20 Nov 2019, Accepted 05 Apr 2020, Published online: 17 Apr 2020

References

  • Acuña-Castroviejo, Darío, Germaine Escames, Carmen Venegas, María E. Díaz-Casado, Elena Lima-Cabello, Luis C. López, Sergio Rosales-Corral, et al. 2014. “Extrapineal Melatonin: Sources, Regulation, and Potential Functions.” Cellular and Molecular Life Sciences 71 (16): 2997–3025. doi:10.1007/s00018-014-1579-2.
  • Adachi, N., T. Numakawa, M. Richards, S. Nakajima, and H. Kunugi. 2014. “New Insight in Expression, Transport, and Secretion of Brain-Derived Neurotrophic Factor: Implications in Brain-Related Diseases.” World Journal of Biological Chemistry 5 (4): 409–428. doi:10.4331/wjbc.v5.i4.409.
  • Alawieh, A., M. Sabra, Z. Sabra, S. Tomlinson, and F. A. Zaraket. 2015. “Molecular Architecture of Spinal Cord Injury Protein Interaction Network.” PLoS One 10 (8): e0135024. doi:10.1371/journal.pone.0135024.
  • Aloe, L., M. L. Rocco, P. Bianchi, and L. Manni. 2012. “Nerve Growth Factor: From the Early Discoveries to the Potential Clinical Use.” Journal of Translational Medicine 10 (1): 239. doi:10.1186/1479-5876-10-239.
  • Amini-Pishva, Akram, Mohammad Akbari, Akram Farahabadi, Ali Arabkheradmand, Cordian Beyer, Nasrin Dashti, Fatemeh Moradi, et al. 2016. “Effect of Estrogen Therapy on TNF-α and iNOS Gene Expression in Spinal Cord Injury Model.” Acta Medica Iranica 54 (5): 296–301.
  • Ansorena, Eduardo, Pauline De Berdt, Bernard Ucakar, Teresa Simón-Yarza, Damien Jacobs, Olivier Schakman, Aleksandar Jankovski, et al. 2013. “Injectable Alginate Hydrogel Loaded with GDNF Promotes Functional Recovery in a Hemisection Model of Spinal Cord Injury.” International Journal of Pharmaceutics 455 (1–2): 148–158. doi:10.1016/j.ijpharm.2013.07.045.
  • Arámburo, C., C. Alba-Betancourt, M. Luna, and S. Harvey. 2014. “Expression and Function of Growth Hormone in the Nervous System: A Brief Review.” General and Comparative Endocrinology 203: 35–42. doi:10.1016/j.ygcen.2014.04.035.
  • Aydemir, S., D. Dogan, A. Kocak, and N. Dilsiz. 2016. “The Effect of Melatonin on Spinal Cord after Ischemia in Rats.” Spinal Cord 54 (5): 360–363. doi:10.1038/sc.2015.204.
  • Aygün, D., S. Kaplan, E. Odaci, M. E. Onger, and M. E. Altunkaynak. 2012. “Toxicity of Non-Steroidal anti-Inflammatory Drugs: A Review of Melatonin and Diclofenac Sodium Association.” Histology and Histopathology 27 : 417–436.
  • Barrera, C. M., A. J. Kastin, M. B. Fasold, and W. A. Banks. 1991. “Bidirectional Saturable Transport of LHRH Across the Blood-Brain Barrier.” American Journal of Physiology-Endocrinology and Metabolism 261 (3): E312–E318. doi:10.1152/ajpendo.1991.261.3.E312.
  • Bear, M., B. Connors, and M. Paradiso. 2016. Neuroscience: Exploring the Brain. 4th ed, 804. Philadelphia USA: Wolters Kluwer. p. ISBN 978-0-7817-7817-6.
  • Beenken, A., and M. Mohammadi. 2009. “The FGF Family: Biology, Pathophysiology and Therapy.” Nature Reviews Drug Discovery 8 (3): 235–253. doi:10.1038/nrd2792.
  • Blesch, A., H. Yang, N. Weidner, A. Hoang, and D. Otero. 2004. “Axonal Responses to Cellularly Delivered NT-4/5 After Spinal Cord Injury.” Molecular and Cellular Neuroscience 27 (2): 190–201. doi:10.1016/j.mcn.2004.06.007.
  • Boyce, V. S., and L. M. Mendell. 2014. “Neurotrophins and Spinal Circuit Function.” Frontiers in Neural Circuits 8: 59. doi:10.3389/fncir.2014.00059.
  • Bregman, B. S., M. McAtee, H. N. Dai, and P. L. Kuhn. 1997. “Neurotrophic Factors Increase Axonal Growth After Spinal Cord Injury and Transplantation in the Adult Rat.” Experimental Neurology 148 (2): 475–494. doi:10.1006/exnr.1997.6705.
  • Brzezinski, A. 1997. “Melatonin in Humans.” New England Journal of Medicine 336 (3): 186–195. doi:10.1056/NEJM199701163360306.
  • Buchman, M., S. Bell, and J. J. Kopchick. 2018. “Growth Hormone Discovery and Structure.” Pediatric Endocrinology Reviews 16 (Suppl 1): 2–10. doi:10.17458/per.vol16.2018.bbk.ghdiscoverystructure.
  • Calderón-Vallejo, D., and J. L. Quintanar. 2012. “Gonadotropin-Releasing Hormone Treatment Improves Locomotor Activity, Urinary Function and Neurofilament Protein Expression After Spinal Cord Injury in Ovariectomized Rats.” Neuroscience Letters. 515 (2): 187–190. doi:10.1016/j.neulet.2012.03.052.
  • Calderón-Vallejo, Denisse, Andrés Quintanar-Stephano, Irma Hernández-Jasso, Violeta Jiménez-Hernández, Jannet Ruiz-Ornelas, Ismael Jiménez, J. Luis Quintanar, et al. 2015. “Functional and Structural Recovery of the Injured Spinal Cord in Rats Treated with Gonadotropin-Releasing Hormone.” Neurochemical Research 40 (3): 455–462. doi:10.1007/s11064-014-1486-9.
  • Chakrabarti, Mrinmay, Arabinda Das, Supriti Samantaray, Joshua A. Smith, Naren L. Banik, Azizul Haque, Swapan K. Ray, et al. 2016. “Molecular Mechanisms of Estrogen for Neuroprotection in Spinal Cord Injury and Traumatic Brain Injury.” Reviews in the Neurosciences 27 (3): 271–281. doi:10.1515/revneuro-2015-0032.
  • Chang, H.-M., H.-C. Wu, Z.-G. Sun, F. Lian, and P. C. K. Leung. 2019. “Neurotrophins and Glial Cell Line-Derived Neurotrophic Factor in the Ovary: Physiological and Pathophysiological Implications.” Human Reproduction Update 25 (2): 224–242. doi:10.1093/humupd/dmy047.
  • Chen, Bingkun K., Nicolas N. Madigan, Jeffrey S. Hakim, Mahrokh Dadsetan, Siobhan S. McMahon, Michael J. Yaszemski, Anthony J. Windebank, et al. 2018. “GDNF Schwann Cells in Hydrogel Scaffolds Promote Regional Axon Regeneration, Remyelination and Functional Improvement after Spinal Cord Transection in Rats.” Journal of Tissue Engineering and Regenerative Medicine 12 (1): e398–e407. doi:10.1002/term.2431.
  • Chen, L., P. K. Lund, S. B. Burgess, B. E. Rudisch, and D. L. McIlwain. 1997. “Growth Hormone, Insulin-like Growth Factor I, and Motoneuron Size.” Journal of Neurobiology 32 (2): 202–212. doi:10.1002/(SICI)1097-4695(199702)32:2<202::AID-NEU5>3.0.CO;2-C.
  • Devesa, J., A. Alonso, N. López, J. García, C. I. Puell, T. Pablos, et al. 2017. “Growth Hormone (GH) and Rehabilitation Promoted Distal Innervation in a Child Affected by Caudal Regression Syndrome.” International Journal of Molecular Sciences 18 (1): 230.
  • Díaz-Galindo, Carmen, Beatriz Gómez-González, Eva Salinas, Denisse Calderón-Vallejo, Irma Hernández-Jasso, Eduardo Bautista, JLuis Quintanar, et al. 2015. “Leuprolide Acetate Induces Structural and Functional Recovery of Injured Spinal Cord in Rats.” Neural Regeneration Research 10 (11): 1819–1824. doi:10.4103/1673-5374.170311.
  • Donnelly, D. J., and P. G. Popovich. 2008. “Inflammation and Its Role in Neuroprotection, Axonal Regeneration and Functional Recovery after Spinal Cord Injury.” Experimental Neurology 209 (2): 378–388. doi:10.1016/j.expneurol.2007.06.009.
  • Dumont, R. J., D. O. Okonkwo, S. Verma, R. J. Hurlbert, P. T. Boulos, D. B. Ellegala, A. S. Dumont, et al. 2001. “Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms.” Clinical Neuropharmacology 24 (5): 254–264. doi:10.1097/00002826-200109000-00002.
  • Engele, J., D. Schubert, and M. C. Bohn. 1991. “Conditioned Media Derived from Glial Cell Lines Promote Survival and Differentiation of Dopaminergic Neurons in Vitro: role of Mesencephalic Glia.” Journal of Neuroscience Research 30 (2): 359–371. doi:10.1002/jnr.490300212.
  • Erol, Fatih S., Metin Kaplan, Murat Tiftikci, Huseyin Yakar, Ibrahim Ozercan, Necip Ilhan, Cahide Topsakal, et al. 2008. “Comparison of the Effects of Octreotide and Melatonin in Preventing Nerve Injury in Rats with Experimental Spinal Cord Injury.” Journal of Clinical Neuroscience 15 (7): 784–790. doi:10.1016/j.jocn.2007.06.009.
  • Erşahin, Mehmet, Zarife Özdemir, Derya Özsavcı, Dilek Akakın, Berrak Ç. Yeğen, Russel J. Reiter, Göksel Şener, et al. 2012. “Melatonin Treatment Protects against Spinal Cord Injury Induced Functional and Biochemical Changes in Rat Urinary Bladder.” Journal of Pineal Research 52 (3): 340–348. doi:10.1111/j.1600-079X.2011.00948.x.
  • Faden, A. I., T. P. Jacobs, and M. T. Smith. 1984. “Thyrotropin-Releasing Hormone in Experimental Spinal Injury: dose Response and Late Treatment.” Neurology 34 (10): 1280–1284. doi:10.1212/WNL.34.10.1280.
  • Faden, A. I., R. Vink, and T. K. McIntosh. 1989. “Thyrotropin-Releasing Hormone and Central Nervous System Trauma.” Annals of the New York Academy of Sciences 553 (1 Thyrotropin-R): 380–384. doi:10.1111/j.1749-6632.1989.tb46659.x.
  • Fang, Hua, Chong Liu, Miao Yang, Huafeng Li, Fangxiang Zhang, Weijing Zhang, Jianping Zhang, et al. 2017. “Neurotrophic Factor and Trk Signaling Mechanisms Underlying the Promotion of Motor Recovery after Acute Spinal Cord Injury in Rats.” Experimental and Therapeutic Medicine 14 (1): 652–656. doi:10.3892/etm.2017.4516.
  • Feng, Shi-qing, Xiao-hong Kong, Yang Liu, De-xiang Ban, Guang-zhi Ning, Jia-tong Chen, Shi-fu Guo, et al. 2009. “Regeneration of Spinal Cord with Cell and Gene Therapy.” Orthopaedic Surgery 1 (2): 153–163. doi:10.1111/j.1757-7861.2009.00018.x.
  • Feuerstein, G., W. E. Lux, D. Ezra, and A. I. Faden. 1984. “Reversal of Leukotriene D4 Hypotension by Thyrotropin-Releasing Hormone.” Neuroscience Research. 2 (1–2): 121–124. doi:10.1016/0168-0102(84)90010-5.
  • Feuerstein, G., W. E. Lux, F. Snyder, D. Ezra, and A. I. Faden. 1984. “Hypotension Produced by Platelet-Activating Factor is Reversed by Thyrotropin-Releasing Hormone.” Circulatory Shock 13 (3): 255–260.
  • Fritsch, M. K. 1994. “ Estrogens, Progestins, and Oral Contraceptives.” In Human Pharmacology. Molecular to Clinical, 482–500. 2a ed. St Louis: Mosby.
  • Fröhlich, E., and R. Wahl. 2019. “The Forgotten Effects of Thyrotropin-Releasing Hormone: Metabolic Functions and Medical Applications.” Frontiers in Neuroendocrinology 52: 29–43. doi:10.1016/j.yfrne.2018.06.006.
  • Genovese, T., E. Mazzon, C. Muià, P. Bramanti, A. De Sarro, and S. Cuzzocrea. 2005. “Attenuation in the Evolution of Experimental Spinal Cord Trauma by Treatment with Melatonin.” Journal of Pineal Research 38 (3): 198–208. doi:10.1111/j.1600-079X.2004.00194.x.
  • Haddadi, G. H., and R. Fardid. 2015. “Oral Administration of Melatonin Modulates the Expression of Tumor Necrosis Factor-α (TNF-α) Gene in Irradiated Rat Cervical Spinal Cord.” Reports of Practical Oncology & Radiotherapy 20 (2): 123–127. doi:10.1016/j.rpor.2014.11.003.
  • Hall, E. D., and J. M. Braughler. 1993. “Free Radicals in CNS Injury.” Research publications – Association for Research in Nervous and Mental Disease 71: 81–105.
  • Hanci, M., C. Kuday, and S. A. Oğuzoğlu. 1994. “The Effects of Synthetic Growth Hormone on Spinal Cord Injury.” Journal of Neurosurgical Sciences 38 (1): 43–49.
  • Harvey, S., and M.-L. Baudet. 2014. “Extrapituitary Growth Hormone and Growth?” General and Comparative Endocrinology 205: 55–61. doi:10.1016/j.ygcen.2014.03.041.
  • Harvey, S., and K. Hull. 2003. “Neural Growth Hormone: An Update.” Journal of Molecular Neuroscience 20 (1): 1–14. doi:10.1385/JMN:20:1:1.
  • Isla, A., M. Budke, A. García-Grande, A. Gómez de la Riva, C. Morales, and J. Rey. 2007. “Protective Effects of the Growth Hormone (GH) on the Irradiated Spinal Cord in Rats.” Neurocirugía 18 (2): 89–94. doi:10.1016/S1130-1473(07)70291-9.
  • Jing, Yingli, Qingbin Wu, Xiaochen Yuan, Bingwei Li, Mingming Liu, Xiaoyan Zhang, Shuying Liu, et al. 2014. “Microvascular Protective Role of Pericytes in Melatonin-Treated Spinal Cord Injury in the C57BL/6 Mice.” Chinese Medical Journal 127 (15): 2808–2813.
  • Kachadroka, S., A. M. Hall, T. L. Niedzielko, S. Chongthammakun, and C. L. Floyd. 2010. “Effect of Endogenous Androgens on 17beta-Estradiol-Mediated Protection after Spinal Cord Injury in Male Rats.” Journal of Neurotrauma 27 (3): 611–626. doi:10.1089/neu.2009.1069.
  • Kaiser, U. B., A. Jakubowiak, A. Steinberger, and W. W. Chin. 1993. “Regulation of Rat Pituitary Gonadotropin-Releasing Hormone Receptor mRNA Levels in Vivo and in Vitro.” Endocrinology 133 (2): 931–934. doi:10.1210/endo.133.2.8393779.
  • Kang, C. E., C. H. Tator, and M. S. Shoichet. 2010. “Poly(Ethylene Glycol) Modification Enhances Penetration of Fibroblast Growth Factor 2 to Injured Spinal Cord Tissue from an Intrathecal Delivery System.” Journal of Controlled Release 144 (1): 25–31. doi:10.1016/j.jconrel.2010.01.029.
  • Kastrup, Y., M. Le Grevès, F. Nyberg, and A. Blomqvist. 2005. “Distribution of Growth Hormone Receptor mRNA in the Brain Stem and Spinal Cord of the Rat.” Neuroscience 130 (2): 419–425. doi:10.1016/j.neuroscience.2004.10.003.
  • Keefe, K. M., I. S. Sheikh, and G. M. Smith. 2017. “Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury.” International Journal of Molecular Sciences. 18 (3): 548. doi:10.3390/ijms18030548.
  • Kelamangalath, L., and G. M. Smith. 2013. “Neurotrophin Treatment to Promote Regeneration after Traumatic CNS Injury.” Frontiers in Biology 8 (5): 486–495. doi:10.1007/s11515-013-1269-8.
  • Krityakiarana, Warin, Kamonrapat Sompup, Nopporn Jongkamonwiwat, Sujira Mukda, Fernando Gomez Pinilla, Piyarat Govitrapong, Pansiri Phansuwan-Pujito, et al. 2016. “Effects of Melatonin on Severe Crush Spinal Cord Injury-Induced Reactive Astrocyte and Scar Formation.” Journal of Neuroscience Research 94 (12): 1451–1459. doi:10.1002/jnr.23930.
  • Lemmon, Vance P., Adam R. Ferguson, Phillip G. Popovich, Xiao-Ming Xu, Diane M. Snow, Michihiro Igarashi, Christine E. Beattie, et al. 2014. “Minimum Information about a Spinal Cord Injury Experiment: A Proposed Reporting Standard for Spinal Cord Injury Experiments.” Journal of Neurotrauma 31 (15): 1354–1361. doi:10.1089/neu.2014.3400.
  • eLi C, Chen X, Qiao S, Liu X, Liu C, Zhu D, et al. 2014. Melatonin lowers edema after spinal cord injury. Neural Regeneration Research 9 (24): 2205–2210. doi: 10.4103/1673-5374.147954.
  • Litwack, G. 2017. Neurotrophins. 1st ed. Cambridge MA: Academic Press.
  • Ludwig, P. E., A. A. Patil, A. J. Chamczuk, and D. K. Agrawal. 2017. “Hormonal Therapy in Traumatic Spinal Cord Injury.” American Journal of Translational Research 9 (9): 3881–3895.
  • Manson, JoAnn E., Rowan T. Chlebowski, Marcia L. Stefanick, Aaron K. Aragaki, Jacques E. Rossouw, Ross L. Prentice, Garnet Anderson, et al. 2013. “Menopausal Hormone Therapy and Health Outcomes during the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials.” JAMA 310 (13): 1353–1368. doi:10.1001/jama.2013.278040.
  • Maquet, V., D. Martin, F. Scholtes, R. Franzen, J. Schoenen, G. Moonen, and R. Jér me. 2001. “Poly(D,L-Lactide) Foams Modified by Poly(Ethylene Oxide)-Block-Poly(D,L-Lactide) Copolymers and a-FGF: In Vitro and in Vivo Evaluation for Spinal Cord Regeneration.” Biomaterials 22 (10): 1137–1146. doi:10.1016/S0142-9612(00)00357-4.
  • Martínez-Moreno, C. G., D. Calderón-Vallejo, S. Harvey, C. Arámburo, and J. L. Quintanar. 2018. “Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?” International Journal of Molecular Sciences 19 (2): 375. doi:10.3390/ijms19020375.
  • McIntosh, T. K., S. Fernyak, R. L. Hayes, and A. I. Faden. 1993. “Beneficial Effect of the Nonselective Opiate Antagonist Naloxone Hydrochloride and the Thyrotropin-Releasing Hormone (TRH) Analog YM-14673 on Long-Term Neurobehavioral Outcome following Experimental Brain Injury in the Rat.” Journal of Neurotrauma 10 (4): 373–384. doi:10.1089/neu.1993.10.373.
  • Monga, V., C. L. Meena, N. Kaur, and R. Jain. 2008. “Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and Its Analogs.” Current Medicinal Chemistry 15 (26): 2718–2733. doi:10.2174/092986708786242912.
  • Naftchi, NE. 1982. “Prevention of Damage in Acute Spinal Cord Injury by Peptides and Pharmacologic Agents.” Peptides 3 (3): 235–247. doi:10.1016/0196-9781(82)90084-5.
  • Namjoo, Zeinab, Fateme Moradi, Roya Aryanpour, Abbas Piryaei, Mohammad Taghi Joghataei, Yusef Abbasi, Amir Hosseini, et al. 2018. “Combined Effects of Rat Schwann Cells and 17β-Estradiol in a Spinal Cord Injury Model.” Metabolic Brain Disease 33 (4): 1229–1242. doi:10.1007/s11011-018-0220-8.
  • Nesic, O., J. Lee, G. C. Unabia, K. Johnson, Z. Ye, L. Vergara, C. E. Hulsebosch, et al. 2008. “Aquaporin 1 - a Novel Player in Spinal Cord Injury.” Journal of Neurochemistry 105 (3): 628–640. doi:10.1111/j.1471-4159.2007.05177.x.
  • Norman, B. H., and J. S. McDermott. 2017. “Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain.” Journal of Medicinal Chemistry 60 (1): 66–88. doi:10.1021/acs.jmedchem.6b00964.
  • Nutt, J. G., K. J. Burchiel, C. L. Comella, J. Jankovic, A. E. Lang, E. R. Laws, A. M. Lozano, et al. 2003. “Randomized, Double-Blind Trial of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in PD.” Neurology 60 (1): 69–73. doi:10.1212/WNL.60.1.69.
  • Nyberg, F., and H. S. Sharma. 2002. “Repeated Topical Application of Growth Hormone Attenuates Blood-Spinal Cord Barrier Permeability and Edema Formation following Spinal Cord Injury: An Experimental Study in the Rat Using Evans Blue, ([125])I-Sodium and Lanthanum Tracers.” Amino Acids 23 (1–3): 231–239. doi:10.1007/s00726-001-0134-2.
  • Ornitz, D. M., and N. Itoh. 2015. “The Fibroblast Growth Factor Signaling Pathway.” Wiley Interdisciplinary Reviews: Developmental Biology 4 (3): 215–266. doi:10.1002/wdev.176.
  • Papka, R. E., M. Storey-Workley, P. J. Shughrue, I. Merchenthaler, J. J. Collins, S. Usip, P. T. K. Saunders, et al. 2001. “Estrogen Receptor-Alpha and Beta- Immunoreactivity and mRNA in Neurons of Sensory and Autonomic Ganglia and Spinal Cord.” Cell and Tissue Research 304 (2): 193–214. doi:10.1007/s004410100363.
  • Periti, P.,. T. Mazzei, and E. Mini. 2002. “Clinical Pharmacokinetics of Depot Leuprorelin.” Clinical Pharmacokinetics 41 (7): 485–504. doi:10.2165/00003088-200241070-00003.
  • Petruska, J. C., and L. M. Mendell. 2009. “Nerve Growth Factor.” In Encyclopedia of Neuroscience, edited by L. R. Squire, 71–78. Oxford: Academic Press.
  • Pitts, L. H., A. Ross, G. A. Chase, and A. I. Faden. 1995. “Treatment with Thyrotropin-Releasing Hormone (TRH) in Patients with Traumatic Spinal Cord Injuries.” Journal of Neurotrauma 12 (3): 235–243. doi:10.1089/neu.1995.12.235.
  • Purves, D., G. Augustine, D. Fitzpatrick, W. Hall, A. LaMantia, J. McNamara, et al. 2004. Neuroscience, 549–555. 3rd ed. Sunderland, MA: Sinauer Associates Inc.
  • Quintanar, José Luis, Carmen Díaz-Galindo, Denisse Calderón-Vallejo, Irma Hernández-Jasso, Froylán Rojas, Daniel Medina-Aguiñaga, Carlos Olvera-Sandoval, et al. 2018. “Neurological Improvement in Patients with Chronic Spinal Cord Injury Treated with Leuprolide Acetate, an Agonist of GnRH.” Acta Neurobiologiae Experimentalis 78 (4): 352–357. doi:10.21307/ane-2018-034.
  • Quintanar, J. L., and I. Guzmán-Soto. 2013. “Hypothalamic Neurohormones and Immune Responses.” Frontiers in Integrative Neuroscience 7: 56. doi:10.3389/fnint.2013.00056.
  • Quintanar, J. L., E. Salinas, and R. González. 2009. “Gonadotropin-Releasing Hormone Receptor in Spinal Cord Neurons of Embryos and Adult Rats.” Neuroscience Letters 461 (1): 21–24. doi:10.1016/j.neulet.2009.06.028.
  • Ren, W., G. Liu, S. Chen, J. Yin, J. Wang, B. Tan, G. Wu, et al. 2017. “Melatonin Signaling in T Cells: Functions and Applications.” Journal of Pineal Research 62 (3): 1–15. 10.1111/jpi.12394
  • Reppert, S. M., D. R. Weaver, S. A. Rivkees, and E. G. Stopa. 1988. “Putative Melatonin Receptors in a Human Biological Clock.” Science 242 (4875): 78–81. doi:10.1126/science.2845576.
  • Ritz, M.-F., and O. N. Hausmann. 2008. “Effect of 17β-Estradiol on Functional Outcome, Release of Cytokines, Astrocyte Reactivity and Inflammatory Spreading after Spinal Cord Injury in Male Rats.” Brain Research 1203: 177–188. doi:10.1016/j.brainres.2008.01.091.
  • Rouleau, P., R.-V. Ung, N. P. Lapointe, and P. A. Guertin. 2007. “Hormonal and Immunological Changes in Mice after Spinal Cord Injury.” Journal of Neurotrauma 24 (2): 367–378. doi:10.1089/neu.2006.0117.
  • Samantaray, Supriti, Arabinda Das, Denise C. Matzelle, Shan P. Yu, Ling Wei, Abhay Varma, Swapan K. Ray, et al. 2016. “Administration of Low Dose Estrogen Attenuates Gliosis and Protects Neurons in Acute Spinal Cord Injury in Rats.” Journal of Neurochemistry 136 (5): 1064–1073. doi:10.1111/jnc.13464.
  • Samantaray, Supriti, Eric A. Sribnick, Arabinda Das, Nakul P. Thakore, Denise Matzelle, Shan P. Yu, Swapan K. Ray, et al. 2010. “Neuroprotective Efficacy of Estrogen in Experimental Spinal Cord Injury in Rats.” Annals of the New York Academy of Sciences 1199 (1): 90–94. doi:10.1111/j.1749-6632.2009.05357.x.
  • Sariola, H., and M. Saarma. 2003. “Novel Functions and Signalling Pathways for GDNF.” Journal of Cell Science 116 (19): 3855–3862. doi:10.1242/jcs.00786.
  • Seo, Kook Heon, Hyun-Mi Ko, Jung Hwa Choi, Hae Hyun Jung, Young Hyun Chun, Il-Whan Choi, Hern-Ku Lee, et al. 2004. “Essential Role for Platelet-Activating Factor-Induced NF-kappaB Activation in Macrophage-Derived Angiogenesis.” European Journal of Immunology 34 (8): 2129–2137. doi:10.1002/eji.200424957.
  • Sharma, H. S. 2007. “A Select Combination of Neurotrophins Enhances Neuroprotection and Functional Recovery following Spinal Cord Injury.” Annals of the New York Academy of Sciences 1122 (1): 95–111. doi:10.1196/annals.1403.007.
  • Shimizu, Takahiro, Tsuyoshi Majima, Takahisa Suzuki, Nobutaka Shimizu, Naoki Wada, Katsumi Kadekawa, Shun Takai, et al. 2018. “Nerve Growth Factor-Dependent Hyperexcitability of Capsaicin-Sensitive Bladder Afferent Neurones in Mice with Spinal Cord Injury.” Experimental Physiology 103 (6): 896–904. doi:10.1113/EP086951.
  • Song, Yong Huan, Yu Ting Zhu, Jian Ding, Fei Ya Zhou, Ji Xin Xue, Jin Hee Jung, Zhi Jie Li, et al. 2016. “Distribution of Fibroblast Growth Factors and Their Roles in Skin Fibroblast Cell Migration.” Molecular Medicine Reports 14 (4): 3336–3342. doi:10.3892/mmr.2016.5646.
  • Sugden, D., K. Davidson, K. A. Hough, and M.-T. Teh. 2004. “Melatonin, Melatonin Receptors and Melanophores: A Moving Story.” Pigment Cell Research 17 (5): 454–460. doi:10.1111/j.1600-0749.2004.00185.x.
  • Thuret, S., L. D. F. Moon, and F. H. Gage. 2006. “Therapeutic Interventions after Spinal Cord Injury.” Nature Reviews Neuroscience 7 (8): 628–643. doi:10.1038/nrn1955.
  • Trupp, M., C. Raynoschek, N. Belluardo, and C. F. Ibáñez. 1998. “Multiple GPI-Anchored Receptors Control GDNF-Dependent and Independent Activation of the c-Ret Receptor Tyrosine Kinase.” Molecular and Cellular Neuroscience 11 (1–2): 47–63. doi:10.1006/mcne.1998.0667.
  • Walker, M. J., and X.-M. Xu. 2018. “History of Glial Cell Line-Derived Neurotrophic Factor (GDNF) and Its Use for Spinal Cord Injury Repair.” Brain Sciences 8 (6): 109. doi: 10.3390/brainsci8060109.
  • Wilson, A. C., S. V. Meethal, R. L. Bowen, and C. S. Atwood. 2007. “Leuprolide Acetate: A Drug of Diverse Clinical Applications.” Expert Opinion on Investigational Drugs 16 (11): 1851–1863. doi:10.1517/13543784.16.11.1851.
  • Winkler, T., H. S. Sharma, E. Stålberg, R. D. Badgaiyan, J. Westman, and F. Nyberg. 2000. “Growth Hormone Attenuates Alterations in Spinal Cord Evoked Potentials and Cell Injury following Trauma to the Rat Spinal Cord. An Experimental Study Using Topical Application of Rat Growth Hormone.” Amino Acids 19 (1): 363–371. doi:10.1007/s007260070067.
  • Wu, J. C., W. C. Huang, Y. C. Chen, T. H. Tu, Y. A. Tsai, S. F. Huang, H. C. Huang, and H. Cheng. 2011. “Acidic Fibroblast Growth Factor for Repair of Human Spinal Cord Injury: A Clinical Trial.” Journal of Neurosurgery: Spine 15 (3): 216–227. doi:10.3171/2011.4.SPINE10404.
  • Wu, Qingbin, Yingli Jing, Xiaochen Yuan, Xiaoyan Zhang, Bingwei Li, Mingming Liu, Bing Wang, et al. 2014. “Melatonin Treatment Protects against Acute Spinal Cord Injury-Induced Disruption of Blood Spinal Cord Barrier in Mice.” Journal of Molecular Neuroscience 54 (4): 714–722. doi:10.1007/s12031-014-0430-4.
  • Xu, G., D. Shi, Z. Zhi, R. Ao, and B. Yu. 2019. “Melatonin Ameliorates Spinal Cord Injury by Suppressing the Activation of Inflammasomes in Rats.” Journal of Cellular Biochemistry 120 (4): 5183–5192. doi:10.1002/jcb.27794.
  • Yang, Jianmin, Chia-Jen Siao, Guhan Nagappan, Tina Marinic, Deqiang Jing, Kelly McGrath, Zhe-Yu Chen, et al. 2009. “Neuronal Release of proBDNF.” Nature Neuroscience 12 (2): 113–115. doi:10.1038/nn.2244.
  • Yang, Long, Min Yao, Yun Lan, Wei Mo, Yue-li Sun, Jing Wang, Yong-jun Wang, et al. 2016. “Melatonin for Spinal Cord Injury in Animal Models: A Systematic Review and Network Meta-Analysis.” Journal of Neurotrauma 33 (3): 290–300. doi:10.1089/neu.2015.4038.
  • Yun, Ye-Rang, Jong Eun Won, Eunyi Jeon, Sujin Lee, Wonmo Kang, Hyejin Jo, Jun-Hyeog Jang, et al. 2010. “Fibroblast Growth Factors: Biology, Function, and Application for Tissue regeneration.” Journal of Tissue Engineering 2010: 218142. doi:10.4061/2010/218142.
  • Zhai, Q., Z. Lai, P. Roos, and F. Nyberg. 1994. “Characterization of Growth Hormone Binding Sites in Rat Brain.” Acta Paediatrica 83 (s406): 92–95. doi:10.1111/j.1651-2227.1994.tb13433.x.
  • Zhang, Fangfang, Lechu Yu, Xiufei Lin, Peng Cheng, Luqing He, Xiaokun Li, Xuemian Lu, et al. 2015. “Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.” Molecular Endocrinology 29 (10): 1400–1413. doi:10.1210/me.2015-1155.
  • Zhang, Hongyu, Fenzan Wu, Xiaoxia Kong, Jie Yang, Huijun Chen, Liancheng Deng, Yi Cheng, et al. 2014. “Nerve Growth Factor Improves Functional Recovery by Inhibiting Endoplasmic Reticulum Stress-Induced Neuronal Apoptosis in Rats with Spinal Cord Injury.” Journal of Translational Medicine 12 (1): 130. doi:10.1186/1479-5876-12-130.
  • Zhang, Yan, Wen-Xiu Zhang, Yan-Jun Zhang, Ya-Dong Liu, Zong-Jian Liu, Qi-Chao Wu, Yun Guan, et al. 2018. “Melatonin for the Treatment of Spinal Cord Injury.” Neural Regeneration Research 13 (10): 1685–1692. doi:10.4103/1673-5374.238603.
  • Zhao, Ying-Zheng, Xi Jiang, Jian Xiao, Qian Lin, Wen-Ze Yu, Fu-Rong Tian, Kai-Li Mao, et al. 2016. “Using NGF Heparin-Poloxamer Thermosensitive Hydrogels to Enhance the Nerve Regeneration for Spinal Cord Injury.” Acta Biomaterialia 29: 71–80. doi:10.1016/j.actbio.2015.10.014.
  • Zheng, B., D. Hao, H. Guo, and B. He. 2017. “Melatonin Alleviates Acute Spinal Cord Injury in Rats Through Promoting on Progenitor Cells Proliferation.” Saudi Pharmaceutical Journal 25 (4): 570–574. doi:10.1016/j.jsps.2017.04.025.
  • Zhou, Y., Z. Wang, J. Li, X. Li, and J. Xiao. 2018. “Fibroblast Growth Factors in the Management of Spinal Cord Injury.” Journal of Cellular and Molecular Medicine 22 (1): 25–37. doi:10.1111/jcmm.13353.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.